Intermede Investment Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SLB Ltd
SLB
|
+$41.3M |
| 2 |
Zoetis
ZTS
|
+$29.3M |
| 3 |
Walt Disney
DIS
|
+$25.6M |
| 4 |
CME Group
CME
|
+$18.1M |
| 5 |
West Pharmaceutical
WST
|
+$16.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applied Materials
AMAT
|
+$138M |
| 2 |
Fidelity National Information Services
FIS
|
+$105M |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$49.8M |
| 4 |
Becton Dickinson
BDX
|
+$38.6M |
| 5 |
Autodesk
ADSK
|
+$10.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 28.03% |
| 2 | Technology | 25.3% |
| 3 | Healthcare | 20.52% |
| 4 | Communication Services | 9.57% |
| 5 | Energy | 6.24% |
Similar funds
Intermede Investment Partners's Q4 2022 Portfolio in Review
As of Q4 2022, Intermede Investment Partners held 28 positions worth $3.58B, up 0.38% from $3.57B the previous quarter. Its ten largest holdings account for 55% of the portfolio.
Intermede Investment Partners withdrew a net $221M in Q4 2022, closing 1 position and reducing 17 holdings. Its most notable exit was Fidelity National Information Services, an estimated $105M position sold in full.
By sector, the portfolio is most concentrated in Financials at 28% of assets, up from 26% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Intermede Investment Partners added an estimated $41.3M to SLB Ltd.
- Intermede Investment Partners added most to SLB Ltd in Q4 2022, an estimated $41.3M increase.
- Intermede Investment Partners's biggest Q4 2022 reduction was Applied Materials, cutting an estimated $138M.
- Intermede Investment Partners fully exited Fidelity National Information Services in Q4 2022, selling an estimated $105M.
- Intermede Investment Partners's ten largest holdings make up 55% of its $3.58B portfolio in Q4 2022.
- Intermede Investment Partners opened 0 new positions and closed 1 in Q4 2022.
- Intermede Investment Partners's portfolio value rose 0.38% quarter-over-quarter to $3.58B.
Based on Intermede Investment Partners's 13F filing for Q4 2022, filed 9 Feb 2023.